IRTC
iRhythm Completes Acquisition of VitalConnect
iRhythm completed the acquisition of VitalConnect to expand its cardiac monitoring portfolio across the continuum of care. This strategic M&A deal is expected to accelerate revenue growth beginning in 2027 while maintaining a 15% adjusted EBITDA margin target.
IRTC
iRhythm Merges With Vital Connect
iRhythm entered into an agreement to merge with Vital Connect, consolidating operations in the cardiac monitoring sector. This strategic alignment is expected to enhance its market presence and service offerings.
BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.